PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Baxter Hlthcare	PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER	magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	017378	NDA	Baxter Healthcare Corporation	0338-0221-03	500 mL in 1 BAG (0338-0221-03)	1979-02-02
Baxter Hlthcare	PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER	magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	017378	NDA	Baxter Healthcare Corporation	0338-0221-04	1000 mL in 1 BAG (0338-0221-04)	1979-02-02
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 11, 2025

Introduction

Plasma-Lyte 148 in Water in Plastic Container is a sterile, balanced electrolyte solution extensively used in clinical settings for fluid therapy, rehydration, and electrolyte management. Its formulation mimics plasma electrolyte composition to maintain acid-base balance and osmotic stability, making it integral in hospitals and infusion centers worldwide. Identifying reliable suppliers is crucial for healthcare providers seeking quality assurance, supply consistency, and regulatory compliance.

Overview of Plasma-Lyte 148

Manufactured by Baxter International, Plasma-Lyte 148 is part of Baxter's line of balanced electrolyte solutions. Its formulation includes sodium, chloride, potassium, magnesium, and acetate, designed to replicate plasma electrolyte balance. Packaged in plastic containers—commonly 100 mL to 1000 mL units—the product underscores sterility and stability, confirmed through rigorous manufacturing standards compliant with pharmacopoeias such as USP, EP, and JP.

Key Suppliers of Plasma-Lyte 148 in Water in Plastic Containers

1. Baxter International Inc.

Overview:
Baxter remains the primary manufacturer and global distributor of Plasma-Lyte 148. With manufacturing facilities adhering to Good Manufacturing Practices (GMP), Baxter ensures product quality, safety, and regulatory compliance.

Availability:
Baxter supplies directly to hospitals, clinics, and authorized distributors worldwide. Their global distribution network enables widespread availability, including North America, Europe, and Asia-Pacific.

Distribution Channels:

Direct hospital contracts
Authorized pharmaceutical distributors
Online procurement via Baxter's official platforms and authorized resellers

Regulatory Compliance:
Baxter's products comply with the FDA (U.S.), EMA (Europe), and other regional regulatory agencies, ensuring adherence to international standards.

2. Authorized Pharmaceutical Distributors and Wholesalers

Given Baxter’s direct distribution limitations, numerous authorized third-party distributors facilitate access to Plasma-Lyte 148 globally. These include:

McKesson Corporation (USA)
A leading healthcare provider distributing Baxter’s products, including Plasma-Lyte 148, across North America.
Cardinal Health (USA)
Supplies Plasma-Lyte 148 through its extensive network, facilitating hospital and pharmacy procurement.
Henry Schein, Inc. (Worldwide)
Offers plasma and infusion solutions, including Plasma-Lyte 148, to healthcare providers globally.
Gunjan Healthcare (India)
An authorized importer and distributor of Baxter products in India, supplying Plasma-Lyte 148 to hospitals and clinics.
Alibaba and Global Trade Platforms
Some authorized pharmaceutical resellers on platforms like Alibaba provide Plasma-Lyte 148, but buyers must verify legitimacy to avoid counterfeit products.

Note: Procurement through these channels should prioritize verified suppliers with certifications confirming authenticity, quality, and regulatory approval.

3. Regional Suppliers and Importers

In regions where Baxter may have limited direct presence, local importers and distributors facilitate access:

Asia-Pacific:
Companies like Yunnan Baiyao Group (China) and Krishna Healthcare (India) have established partnerships with Baxter for product distribution.
Middle East & Africa:
Several regional distributors with authorized Baxter import licenses supply Plasma-Lyte 148, including Al Zahrawi Medical and Al-Harithy Company for Trading Est.
Europe:
Baxter’s European subsidiaries distribute Plasma-Lyte 148 directly or through authorized partners.

Regulatory compliance is vital, requiring buyers to verify the distributor’s authorization and adherence to regional GMP standards.

Considerations When Sourcing Plasma-Lyte 148

Authenticity & Quality Assurance:
Always procure from authorized suppliers to prevent counterfeit products. Verify product packaging, batch numbers, and certifications.
Regulatory Certification:
Ensure the supplier complies with local and international regulatory standards (FDA, EMA, WHO) and provides certificates of analysis and Good Manufacturing Practice certificates.
Supply Chain Reliability:
Given the critical role of Plasma-Lyte 148, choose suppliers with proven logistics capabilities and inventory stability to avoid shortages.
Pricing & Contract Terms:
Negotiations should balance cost considerations with quality assurances, considering bulk procurement discounts and service agreements.

Emerging Suppliers & Future Trends

Regional Manufacturing:
Some emerging markets are developing local manufacturing capabilities, potentially reducing dependence on imports, and lowering costs.
Partnerships & Licensing:
Baxter has entered licensing agreements with regional players to expand access, which may widen supplier networks.
Supply Chain Digitalization:
Adoption of blockchain and real-time tracking enhances transparency and traceability, helping ensure supplier authenticity.

Conclusion

The primary supplier of Plasma-Lyte 148 in Water in Plastic Containers is Baxter International Inc., supported by an extensive global network of authorized distributors and regional importers. Ensuring product authenticity, regulatory compliance, and supply reliability are paramount for healthcare providers. For procurement strategies, prioritizing verified sources and understanding regional distribution channels minimizes risks associated with counterfeit or substandard products.

Key Takeaways

Baxter International is the principal manufacturer and primary supplier of Plasma-Lyte 148, globally accessible through authorized distributors and regional partners.
Procurement should emphasize verifying supplier authenticity, certifications, and regulatory compliance to ensure patient safety.
Regional distributors and importers expand access, especially in areas where Baxter's direct distribution may be limited.
The healthcare sector benefits from emerging supply chain technologies and local manufacturing, improving supply stability and cost-efficiency.
Establishing long-term relationships with trusted distributors enhances supply reliability and quality assurance.

FAQs

1. Can I procure Plasma-Lyte 148 directly from Baxter?
Yes, large hospital systems or authorized entities can purchase directly through Baxter's corporate channels, often via contractual agreements.

2. What should I verify before purchasing Plasma-Lyte 148 from a distributor?
Verify the distributor’s authorization, certifications, product batch numbers, expiration dates, and compliance with regional regulatory standards.

3. Are there regional alternatives to Baxter for Plasma-Lyte 148?
While Baxter remains the primary manufacturer, regional licensed manufacturers and authorized importers may supply equivalent electrolyte solutions, but authenticity and quality verification are critical.

4. What risks exist when buying from unverified sources?
Potential risks include counterfeit products, substandard quality, compromised sterility, and regulatory infractions, which can jeopardize patient safety and legal compliance.

5. How is the supply chain of Plasma-Lyte 148 evolving?
Supply chains are increasingly digitized and diversified, with regional manufacturing, licensing agreements, and improved logistics ensuring broader availability and enhanced traceability.

Sources:

[1] Baxter International Inc. Product Information and Distribution Networks.
[2] World Health Organization (WHO) guidelines on electrolyte solutions.
[3] Regulatory filings and approvals from FDA and EMA.
[4] Market reports on infusion and electrolyte solution distribution.

Suppliers and packagers for PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER